Big Pharma — vision

Vision-Related Implications of COVID-19 can be Mitigated with Appropriate Care   New York, NY, October , 2020 — About 30 percent of those diagnosed with COVID-19 experience conjunctivitis (an eye infection), and countless others with ocular diseases that require ongoing evaluation and treatment are skipping their checkups out of fears of contracting COVID-19.   Dr. Daniel Laroche, Director of Glaucoma Services and President of Advanced Eyecare of New York, emphasizes that, while the pandemic may have changed the way we visit our doctors, it’s imperative that we stay up-to-date with our vision exams, particularly for those with conditions such as...